Engeholm Maik, Sekler Julia, Schöndorf David C, Arora Vineet, Schittenhelm Jens, Biskup Saskia, Schell Caroline, Gasser Thomas
Department of Neurology and Hertie Institute for Clinical Brain Research, Hoppe-Seyler-Str, 3, 72076 Tübingen, Germany.
BMC Neurol. 2014 Jun 3;14:118. doi: 10.1186/1471-2377-14-118.
Charcot-Marie-Tooth disease (CMT) refers to a heterogeneous group of genetic motor and sensory neuropathies. According to the primary site of damage, a distinction is made between demyelinating and axonal forms (CMT1 and 2, respectively, when inherited as an autosomal dominant trait). Leucine-rich repeat and sterile alpha motif-containing protein 1 (LRSAM1) is a ubiquitin-protein ligase with a role in sorting internalised cell-surface receptor proteins. So far, mutations in the LRSAM1 gene have been shown to cause axonal CMT in three different families and can confer either dominant or recessive transmission of the disease.
We have identified a novel mutation in LRSAM1 in a small family with dominant axonal CMT. Electrophysiological studies show evidence of a sensory axonal neuropathy and are interesting in so far as giant motor unit action potentials (MUAPs) are present on needle electromyography (EMG), while motor nerve conduction studies including compound motor action potential (CMAP) amplitudes are completely normal. The underlying mutation c.2046+1G >T results in the loss of a splice donor site and the inclusion of 63 additional base pairs of intronic DNA into the aberrantly spliced transcript. This disrupts the catalytically active RING (Really Interesting New Gene) domain of LRSAM1.
Our findings suggest that, beyond the typical length-dependent degeneration of motor axons, damage of cell bodies in the anterior horn might play a role in LRSAM1-associated neuropathies. Moreover, in conjunction with other data in the literature, our results support a model, by which disruption of the C-terminal RING domain confers dominant negative properties to LRSAM1.
夏科-马里-图斯病(CMT)是一组异质性的遗传性运动和感觉神经病变。根据损伤的主要部位,可分为脱髓鞘型和轴索性(分别为CMT1型和CMT2型,以常染色体显性性状遗传时)。富含亮氨酸重复序列和无活性α基序蛋白1(LRSAM1)是一种泛素蛋白连接酶,在分选内化的细胞表面受体蛋白中起作用。到目前为止,已证明LRSAM1基因突变在三个不同家族中导致轴索性CMT,并可导致疾病的显性或隐性遗传。
我们在一个患有显性轴索性CMT的小家族中发现了LRSAM1基因的一种新突变。电生理研究显示存在感觉轴索性神经病变的证据,有趣的是,针极肌电图(EMG)显示有巨大运动单位动作电位(MUAPs),而包括复合运动动作电位(CMAP)波幅在内的运动神经传导研究完全正常。潜在的突变c.2046+1G>T导致一个剪接供体位点缺失,异常剪接的转录本中包含63个额外的内含子DNA碱基对。这破坏了LRSAM1具有催化活性的RING(真有趣的新基因)结构域。
我们的研究结果表明,除了运动轴突典型的长度依赖性退变外,前角细胞体的损伤可能在LRSAM1相关神经病变中起作用。此外,结合文献中的其他数据,我们的结果支持一种模型,即C末端RING结构域的破坏赋予LRSAM1显性负性特性。